Caris Diagnostics Announces Addition of Leading Dermatopathologist to Expand Subspecialty... (ecognized and appreciated among the medi...)

Caris Diagnostics Announces Addition of Leading Dermatopathologist to Expand Subspecialty Expertise

Date:1/15/2008

ecognized and appreciated among the medical community," concluded Richard H. Lash, M.D., Chief Medical Officer of Caris Diagnostics. "We have found that our dedication to providing the highest level of subspecialty diagnostics in a supportive environment that includes research and education is appealing to the finest pathologists in the country."

About Caris Diagnostics

Caris Diagnostics is a leading provider of the highest quality diagnostic services in anatomic pathology and molecular testing. Caris Diagnostics provides world-class surgical pathology services to physicians who treat patients in an ambulatory setting. The company provides academic-caliber medical consults through its industry-leading team of subspecialty fellowship and expert-trained pathologists in gastrointestinal and liver pathology and dermatopathology. Caris Diagnostics provides the highest levels of service to its customers and their patients through its state-of-the-art laboratories; proprietary, advanced clinical and technology solutions; and rigorous quality assurance programs. Through the cutting-edge testing facilities of Caris MPI, the company also offers advanced analysis of patient samples through prognostic testing services and genomic and proteomic profiling to help guide physicians in the treatment of cancer and other complex diseases. As well, Caris MPI offers a single-source solution for biospecimen procurement, storage, tracking, analysis and reporting for research institutes, pharmaceutical and diagnostic companies and medical centers. More than 1,500 physicians nationally use Caris Diagnostics. Formed in 1996, the company is headquartered in Irving, Texas and operates four laboratories: Irving, Texas; Phoenix, Arizona (2 sites); and Newton, Massachusetts. Additional information is available at http://www.carisdx.com.

SOURCE Caris Diagnostics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. FDA Approves SOMA(R) (carisoprodol) 250 mg
2. Dominion Diagnostics Supports Rhode Islands Toys for Tots Initiative at Its 2007 Holiday Celebration
3. Quest Diagnostics to Speak at the Merrill Lynch Health Services Investor Conference
4. Studies Investigate Diagnostic Performance and Reproducibility of Pathwork Diagnostics Tissue of Origin Test
5. DeviceSpace Career Fair Opens Doors for Hundreds of Medical Device and Diagnostics Career Candidates
6. QED International Associates Announces Changes to the HealthShares(TM) Composite, and the HealthShares(TM) Diagnostics Indexes
7. GSW Worldwide Named Agency of Record for BioBehavioral Diagnostics Companys MMAT/ADHD(TM) System
8. Quest Diagnostics Licenses Technology Underlying SensiTrop(TM) HIV Co-Receptor Tropism Test from Pathway Diagnostics
9. ICx Technologies and Siemens Medical Solutions Diagnostics Enter In Vitro Diagnostics Development and License Option Agreement
10. Quest Diagnostics Reports Third Quarter Results
11. Optherion Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostics Based on Chromosome 10 Genetic Variations

Post Your Comments:

Caris Diagnostics Announces Addition of Leading Dermatopathologist to Expand Subspecialty...(ecognized and appreciated among the medi...),Health